Health
Moderna’s mRNA Flu Vaccine to Face FDA Review
Moderna’s experimental mRNA flu vaccine will be reviewed by an FDA advisory panel next month. The review follows the firing of former agency head Marty Makary.
Coverage timeline — 1 article
The Hill
Moderna’s experimental mRNA flu shot will be reviewed by a Food and Drug Administration advisory panel next month, a move that suggests a more stable approach to drug reviews after the firing of former agency head Marty Makary. The panel will meet on June 18 to discuss and make recommendations on t
2026-05-21 21:53 UTC